New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

Updated on: March 25,2024

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

Updated on:March 25,2024

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Updated on: August 27,2024

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Updated on:August 27,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on: April 14,2024

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Updated on:April 14,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on: December 20,2023

Breast density notification laws not effective for all women

byYale UniversityA new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.The

Updated on:December 20,2023

Does this cause cancer? How scientists determine whether a chemical is carcinogenic

by Brad Reisfeld,The ConversationPeople areexposed to numerous chemicalsthroughout their lifetimes. These chemicals can be from the air, foods, personal care items, household product

Updated on: February 18,2024

Does this cause cancer? How scientists determine whether a chemical is carcinogenic

by Brad Reisfeld,The ConversationPeople areexposed to numerous chemicalsthroughout their lifetimes. These chemicals can be from the air, foods, personal care items, household product

Updated on:February 18,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on: December 25,2023

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on:December 25,2023

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024

Surprising connection between COVID-19 and cancer regression

byNorthwestern UniversityCredit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI179527A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute

Updated on: December 01,2024

Surprising connection between COVID-19 and cancer regression

byNorthwestern UniversityCredit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI179527A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute

Updated on:December 01,2024

Colon cancer screenings are more effective than previously understood: Study

by Peter Dizikes,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainScreening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized

Updated on: December 30,2023

Colon cancer screenings are more effective than previously understood: Study

by Peter Dizikes,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainScreening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized

Updated on:December 30,2023